Literature DB >> 21074746

Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions.

Arezou Sadighi Akha1, Joseph Rosa, Jonathan S Jahr, Alvin Li, Kianusch Kiai.   

Abstract

Neuromuscular blocking agents are widely used in perioperative medicine to aid in endotracheal intubation, facilitate surgery, and in critical care/emergency medicine settings. Muscle relaxants have profound clinical uses in current surgical and intensive care and emergency medical therapy. This article reviews cyclodextrins, development of selective binding agents, clinical development, and future directions of sugammadex.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074746     DOI: 10.1016/j.anclin.2010.08.014

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN: 1932-2275


  8 in total

1.  Expert consensus for a national essential antidote list: E-Delphi method.

Authors:  Dalal Al-Taweel; Samuel Koshy; Sara Al-Ansari; Asmaa Al-Haqan; Bedoor Qabazard
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

2.  Novel drug development for neuromuscular blockade.

Authors:  Amit Prabhakar; Alan D Kaye; Melville Q Wyche; Orlando J Salinas; Kenneth Mancuso; Richard D Urman
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Jul-Sep

3.  Repeat dosing of rocuronium-sugammadex: unpredictable.

Authors:  Yoon-Hee Kim
Journal:  Korean J Anesthesiol       Date:  2014-07

4.  Neuronal Effects of Sugammadex in combination with Rocuronium or Vecuronium.

Authors:  Martin Aldasoro; Adrian Jorda; Constanza Aldasoro; Patricia Marchio; Sol Guerra-Ojeda; Marc Gimeno-Raga; Mª Dolores Mauricio; Antonio Iradi; Elena Obrador; Jose Mª Vila; Soraya L Valles
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

5.  A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block.

Authors:  Chang-Hoon Koo; Jin-Young Hwang; Seong-Won Min; Jung-Hee Ryu
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

Review 6.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

7.  Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures.

Authors:  José M Palanca; Diana Aguirre-Rueda; Manuel V Granell; Martin Aldasoro; Alma Garcia; Antonio Iradi; Elena Obrador; Maria Dolores Mauricio; Jose Vila; Anna Gil-Bisquert; Soraya L Valles
Journal:  Int J Med Sci       Date:  2013-08-03       Impact factor: 3.738

8.  [Influence of methylprednisolone on the reversal time of sugammadex: a randomized clinical trial].

Authors:  Merve Hayriye Kocaoğlu; Başak Ceyda Meço; Menekşe Özçelik; Yeşim Batislam
Journal:  Braz J Anesthesiol       Date:  2020-05-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.